In order to meet the requirements of the Swiss Ordinance on Clinical Trials with medicinal products (=drugs), FGK Representative Service AG has been set up to serve as the sponsor’s Swiss representative and act as the main contact for the Swiss authorities and ethics committees.
On 26 May 2021, the Swiss Ordinance on Clinical Trials with Medical Devices will become applicable. This ordinance requires for Sponsors without subsidiary or establishment in Switzerland to assign a representative in Switzerland. FGK Representative Service AG can provide the service of Swiss representation for both sponsors of clinical trials with medicinal products (=drugs) and for clinical investigations with medical devices.
FGK Representative Service AG
5637 Beinwil (Freiamt)
Phone: +41 43 508 3632